Brainstorm Cell Therapeutics shares owned by Jmac Enterprises
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Jmac Enterprises
from 13F filings
Historical chart of Jmac Enterprises investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Jmac Enterprises consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Jmac Enterprises
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $18k | 65k | 0.27 |
| 2023-09-30 | $13k | 65k | 0.20 |
| 2023-06-30 | $83k | 40k | 2.06 |
| 2023-03-31 | $133k | 40k | 3.30 |
| 2022-12-31 | $66k | 40k | 1.64 |
| 2022-09-30 | $179k | 40k | 4.43 |
| 2022-06-30 | $125k | 45k | 2.75 |
| 2022-03-31 | $153k | 45k | 3.37 |